Bausch Health Companies (BHC) Long-Term Deferred Tax (2009 - 2026)

At the end of FY2025, Bausch Health Companies' Long-Term Deferred Tax came in at $1.84 billion, down 6.4% from FY2024.

• Annual Long-Term Deferred Tax has declined for four consecutive years, with a five-year compound annual growth rate of -2.9% (FY2020 to FY2025).
• In prior years, Bausch Health Companies' Long-Term Deferred Tax was $1.97 billion in FY2024 (-6.3%), $2.1 billion in FY2023 (-3.0%), $2.17 billion in FY2022 (-3.8%) and $2.25 billion in FY2021 (+5.4%).
• Quarterly Long-Term Deferred Tax has run from a low of $1.84 billion in Q4 2025 to a high of $2.37 billion in Q3 2022 over five years.
• On a year-over-year basis, Long-Term Deferred Tax has declined in each of the last seven quarters, with an average decline of 6.3% over the last eight quarters.
• The strongest year-over-year quarter for Long-Term Deferred Tax in the past five years was Q3 2021, with growth of 18.5%; the weakest was Q2 2026, with a decline of 8.9%.
• According to Business Quant data, Long-Term Deferred Tax for the three prior quarters was $1.85 billion (Q1 2026), $1.84 billion (Q4 2025) and $2.05 billion (Q3 2025).